Barclays Maintains Equal-Weight on Biomea Fusion, Raises Price Target to $9
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Peter Lawson maintains an Equal-Weight rating on Biomea Fusion (NASDAQ:BMEA) and raises the price target from $5 to $9.
September 27, 2024 | 2:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays analyst Peter Lawson has maintained an Equal-Weight rating on Biomea Fusion and increased the price target from $5 to $9, indicating a more optimistic outlook.
The increase in the price target from $5 to $9 by Barclays suggests a more positive outlook on Biomea Fusion's future performance. This could lead to increased investor interest and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100